These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 15646088)
1. Sepsis and the role of activated protein C. Tazbir J Crit Care Nurse; 2004 Dec; 24(6):40-5. PubMed ID: 15646088 [No Abstract] [Full Text] [Related]
2. Recombinant human activated protein C. Hughes M Int J Antimicrob Agents; 2006 Aug; 28(2):90-4. PubMed ID: 16837170 [TBL] [Abstract][Full Text] [Related]
3. Activated protein C for severe sepsis. Ely EW; Bernard GR; Vincent JL N Engl J Med; 2002 Sep; 347(13):1035-6. PubMed ID: 12324564 [No Abstract] [Full Text] [Related]
5. Activated protein C: the cure for sepsis - again? Hoth T; Evans TW Anaesthesia; 2001 Dec; 56(12):1133-5. PubMed ID: 11736767 [No Abstract] [Full Text] [Related]
6. Steroids and drotrecogin alfa (activated) for severe sepsis. Steingrub JS Chest; 2003 Nov; 124(5):2033. PubMed ID: 14605088 [No Abstract] [Full Text] [Related]
7. [Hemorrhagic risk of drotrecogin alfa (activated) in severe sepsis]. Perrotin D Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():16-9. PubMed ID: 15359934 [No Abstract] [Full Text] [Related]
8. Drotrecogin alfa: a role in emergency department treatment of severe sepsis? McLeay AM Emerg Med Australas; 2004 Aug; 16(4):324-35. PubMed ID: 15283720 [TBL] [Abstract][Full Text] [Related]
9. [The FDA's questions]. Opal S Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():20-2. PubMed ID: 15359935 [No Abstract] [Full Text] [Related]
10. Drotrecogin alfa: too early to give it early. Smith B Emerg Med Australas; 2005 Apr; 17(2):179-80. PubMed ID: 15796737 [No Abstract] [Full Text] [Related]
11. [PROWESS: description and key results]. Vallet B Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():12-5. PubMed ID: 15359933 [No Abstract] [Full Text] [Related]
12. Recombinant human activated protein C for severe sepsis. Ott A; Verbrugh HA N Engl J Med; 2001 Jul; 345(3):220; author reply 220-1. PubMed ID: 11463023 [No Abstract] [Full Text] [Related]
13. Low-dose heparin for severe sepsis. Davidson BL; Geerts WH; Lensing AW N Engl J Med; 2002 Sep; 347(13):1036-7. PubMed ID: 12324565 [No Abstract] [Full Text] [Related]
14. Drotrecogin alfa (activated) for severe sepsis. Maglio D Conn Med; 2002 Mar; 66(3):145-50. PubMed ID: 11957766 [No Abstract] [Full Text] [Related]
15. From the Food and Drug Administration. Schwetz BA JAMA; 2002 Jan; 287(1):33. PubMed ID: 11754690 [No Abstract] [Full Text] [Related]
16. Recombinant human activated protein C for severe sepsis. Kapur S; Kupfer Y; Tessler S N Engl J Med; 2001 Jul; 345(3):219-20; author reply 220-1. PubMed ID: 11463021 [No Abstract] [Full Text] [Related]
17. Recombinant human activated protein C for severe sepsis. Greisman SE; Johnston CA; Gosnell MS N Engl J Med; 2001 Jul; 345(3):219; author reply 220-1. PubMed ID: 11463022 [No Abstract] [Full Text] [Related]
18. [Medical-economic evaluation of severe sepsis]. Guidet B Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():28-30. PubMed ID: 15359937 [No Abstract] [Full Text] [Related]
19. Treatment of severe sepsis with Xigris: implications for the clinical nurse specialist. Powers J; Jacobi J Clin Nurse Spec; 2003 May; 17(3):128-30. PubMed ID: 12792186 [No Abstract] [Full Text] [Related]
20. [Activated protein C (the impact of PROWESS trial)]. Iba T; Kidokoro A Nihon Rinsho; 2004 Dec; 62(12):2296-300. PubMed ID: 15597799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]